Literature DB >> 22404039

Genome-wide analysis of cytogenetic aberrations in ETV6/RUNX1-positive childhood acute lymphoblastic leukaemia.

Louise Borst1, Agata Wesolowska, Tejal Joshi, Rehannah Borup, Finn C Nielsen, Mette K Andersen, Olafur G Jonsson, Peder S Wehner, Finn Wesenberg, Britt-Marie Frost, Ramneek Gupta, Kjeld Schmiegelow.   

Abstract

The chromosomal translocation t(12;21) resulting in the ETV6/RUNX1 fusion gene is the most frequent structural cytogenetic abnormality among patients with childhood acute lymphoblastic leukaemia (ALL). We investigated 62 ETV6/RUNX1-positive childhood ALL patients by single nucleotide polymorphism array to explore acquired copy number alterations (CNAs) at diagnosis. The mean number of CNAs was 2·82 (range 0-14). Concordance with available G-band karyotyping and comparative genomic hybridization was 93%. Based on three major protein-protein complexes disrupted by these CNAs, patients could be categorized into four distinct subgroups, defined by different underlying biological mechanisms relevant to the aetiology of childhood ALL. When recurrent CNAs were evaluated by an oncogenetic tree analysis classifying their sequential order, the most common genetic aberrations (deletions of 6q, 9p, 13q and X, and gains of 10 and 21) seemed independent of each other. Finally, we identified the most common regions with recurrent gains and losses, which comprise microRNA clusters with known oncogenic or tumour-suppressive roles. The present study sheds further light on the genetic diversity of ETV6/RUNX1-positive childhood ALL, which may be important for understanding poor responses among this otherwise highly curable subset of ALL and lead to novel targeted treatment strategies.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22404039     DOI: 10.1111/j.1365-2141.2012.09083.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  9 in total

1.  BCR-ABL1 gene rearrangement as a subclonal change in ETV6-RUNX1-positive B-cell acute lymphoblastic leukemia.

Authors:  Karen A Dun; Rob Vanhaeften; Tracey J Batt; Louise A Riley; Giuseppe Diano; Jan Williamson
Journal:  Blood Adv       Date:  2016-11-30

2.  Copy number genome alterations are associated with treatment response and outcome in relapsed childhood ETV6/RUNX1-positive acute lymphoblastic leukemia.

Authors:  Almut Bokemeyer; Cornelia Eckert; Franziska Meyr; Gabriele Koerner; Arend von Stackelberg; Reinhard Ullmann; Seval Türkmen; Günter Henze; Karl Seeger
Journal:  Haematologica       Date:  2013-11-15       Impact factor: 9.941

3.  Use of Genome Engineering to Create Patient Specific MLL Translocations in Primary Human Hematopoietic Stem and Progenitor Cells.

Authors:  Erin H Breese; Corina Buechele; Catherine Dawson; Michael L Cleary; Matthew H Porteus
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

4.  Whole-Exome Sequencing of ETV6/RUNX1 in Four Childhood Acute Lymphoblastic Leukaemia Cases

Authors:  Zubaidah Zakaria; Norodiyah Othman; Azli Ismail; Nor Rizan Kamaluddin; Ezalia Esa; Eni Juraida Abdul Rahman; Yuslina Mat Yusoff; Fazlin Mohd Fauzi; Ten Sew Keoh
Journal:  Asian Pac J Cancer Prev       Date:  2017-04-01

Review 5.  Pathogenesis of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia and mechanisms underlying its relapse.

Authors:  Congcong Sun; Lixian Chang; Xiaofan Zhu
Journal:  Oncotarget       Date:  2017-05-23

6.  ETV6/RUNX1-positive childhood acute lymphoblastic leukemia in China: excellent prognosis with improved BFM protocol.

Authors:  Yu Wang; Hui-Min Zeng; Le-Ping Zhang
Journal:  Ital J Pediatr       Date:  2018-08-16       Impact factor: 2.638

7.  A somatic UBA2 variant preceded ETV6-RUNX1 in the concordant BCP-ALL of monozygotic twins.

Authors:  Benedicte Bang; Jesper Eisfeldt; Gisela Barbany; Arja Harila-Saari; Mats Heyman; Vasilios Zachariadis; Fulya Taylan; Ann Nordgren
Journal:  Blood Adv       Date:  2022-04-12

8.  A common genetic variation in CEBPE and acute lymphoblastic leukemia: a meta-analysis of the available evidence.

Authors:  Xiao-Xia Zhang; Yue-Feng Du; Ya-Jing Zhai; Fan Gao; Yu-Juan Yang; Xian-Cang Ma; Jun Lu; Jie Zheng
Journal:  Onco Targets Ther       Date:  2015-09-07       Impact factor: 4.147

9.  Outcome and Prognostic Factors for ETV6/RUNX1 Positive Pediatric Acute Lymphoblastic Leukemia Treated at a Single Institution in Korea.

Authors:  Jae Wook Lee; Seong-Koo Kim; Pil-Sang Jang; Nack-Gyun Chung; Dae-Chul Jeong; Myungshin Kim; Bin Cho; Hack-Ki Kim
Journal:  Cancer Res Treat       Date:  2016-08-10       Impact factor: 4.679

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.